Journal of The American Academy of Dermatology

Journal

Publication Venue For

  • No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis.  83:375-381. 2020
  • Morphea-like skin lesions reported in the Phase III Long-term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis. 2020
  • Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.  82:1445-1486. 2020
  • Improvement of 11 patients with nail psoriasis with apremilast: results of an investigator-initiated open-label study. 2020
  • Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.  82:161-201. 2020
  • Negative predictive value of biopsy margins of dysplastic nevi: A single-institution retrospective review.  82:87-93. 2020
  • Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.  81:775-804. 2019
  • Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.  80:1073-1113. 2019
  • Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.  80:1029-1072. 2019
  • More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations.  80:617-625. 2019
  • Association of 25-hydroxyvitamin D levels and cutaneous melanoma: A nested case-control study of the Women's Health Initiative Observation Study.  79:145-147. 2018
  • Guidelines of care for the management of basal cell carcinoma.  78:540-559. 2018
  • Guidelines of care for the management of cutaneous squamous cell carcinoma.  78:560-578. 2018
  • Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study.  78:264-269. 2018
  • Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.  78:90-99.e1. 2018
  • Randomized controlled pilot study of the preoperative use of brimonidine 0.33% topical gel for hemostasis in Mohs micrographic surgery.  77:1114-1118. 2017
  • High prevalence of combination tanning among undergraduates: Survey at a southeastern US university.  77:968-970. 2017
  • Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis.  77:79-87.e1. 2017
  • The impact of oral Polypodium leucotomos extract on ultraviolet B response: A human clinical study.  77:33-41.e1. 2017
  • Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.  76:1077-1083.e3. 2017
  • Response to A financial perspective on the topical treatment of onychomycosis.  75:e39. 2016
  • Successful treatment of refractory Hailey-Hailey disease with a 595-nm pulsed dye laser: A series of 7 cases.  72:735-737. 2015
  • Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.  73:62-69. 2015
  • Tanning accelerators: Prevalence, predictors of use, and adverse effects.  72:99-104. 2015
  • Using better understanding of anatomy to improve surgical assistants' utility.  71:e245-e246. 2014
  • Erratum: Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies(Journal of the American Academy of Dermatology (2013) 68 (600-8)).  70:399. 2014
  • Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis Work Group.  70:338-351. 2014
  • Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies.  71:116-132. 2014
  • Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents.  71:327-349. 2014
  • Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches Work Group.  71:1218-1233. 2014
  • Research gaps in psoriasis: Opportunities for future studies.  70:146-167. 2014
  • Rickettsia parkeri: Eschar diagnosis.  71. 2014
  • Sirolimus-associated regression of benign lymphangioendothelioma.  71:e221-e222. 2014
  • Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser.  69:578-582. 2013
  • Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.  68:600-608. 2013
  • A large tumor on the right forearm.  66. 2012
  • Skin cancer risk perceptions: A comparison across ethnicity, age, education, gender, and income.  66:771-779. 2012
  • Compliance with sunscreen advice in a survey of adults engaged in outdoor winter recreation at high-elevation ski areas.  66:63-70. 2012
  • Lichen planus pemphigoides in a 2-year-old girl: Response to treatment with methotrexate.  67. 2012
  • Neutrophilic dermatosis revisited: An initial presentation of lupus?.  67. 2012
  • Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma.  67:1375-1379. 2012
  • Fulminant myocarditis as a late sequela of DRESS: Two cases.  65:889-890. 2011
  • Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions.  65:137-174. 2011
  • Phenotypic variability among café-au-lait macules in neurofibromatosis type 1.  63:440-447. 2010
  • Cyclosporine and psoriasis: 2008 National Psoriasis Foundation* Consensus Conference.  62:838-853. 2010
  • Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy.  62:114-135. 2010
  • Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.  61:451-485. 2009
  • Neurofibromatosis type 1.  61:1-14. 2009
  • Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.  60:643-659. 2009
  • Lack of classic histology should not prevent diagnosis of necrolytic acral erythema.  60:504-507. 2009
  • Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: Results of two randomized, investigator-blinded, multicenter, international, controlled trials*.  59:41-54. 2008
  • Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.  58:826-850. 2008
  • Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 2. Psoriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics.  58:851-864. 2008
  • The prevalence of acne in adults 20 years and older.  58:56-59. 2008
  • Reply.  57:728. 2007
  • Onychomycosis: Diagnosis and definition of cure.  56:939-944. 2007
  • New opportunities in preventative dermatology: How far should we go?.  56:675-676. 2007
  • Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.  56:439.e1-439.e10. 2007
  • Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial.  54. 2006
  • A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.  53:798-809. 2005
  • Surgical Pearl: Preventing perioperative exposure keratopathy.  53:707-708. 2005
  • Surgical Pearl: The "fishhook" needle technique: A solution to the large needle, small space dilemma.  53:144-146. 2005
  • Cutaneous lymphoid hyperplasia and marginal zone B-cell lymphoma following vaccination.  53:511-515. 2005
  • Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma.  52:798-802. 2005
  • Modification of the nail psoriasis severity index [8] (multiple letters).  53:745-746. 2005
  • Molecular diagnostics in melanoma.  52:743-775. 2005
  • Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery.  51:585-591. 2004
  • Improvement in nail psoriasis with alefacept.  50:P145-P145. 2004
  • Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002.  50:748-752. 2004
  • Guidelines of care for atopic dermatitis.  50:391-404. 2004
  • Tinea capitis in adult women masquerading as bacterial pyoderma.  49:177-179. 2003
  • Tinea capitis in adult women masquerading as bacterial pyoderma..  49:S177-S179. 2003
  • Tinea capitis in Cleveland: Survey of elementary school students.  48:189-193. 2003
  • Cutaneous anthrax management algorithm.  47:766-769. 2002
  • Infliximab for the treatment of severe pustular psoriasis [1].  47:796-797. 2002
  • Reactivity to trichophytin antigen in patients with onychomycosis: Effect of terbinafine.  46:371-375. 2002
  • Reply.  45:320-321. 2001
  • A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.  44:940-947. 2001
  • Cutaneous photoprotection from ultraviolet injury by green tea polyphenols.  44:425-432. 2001
  • Facial and abdominal hair growth in hirsutism: A computerized evaluation.  45:846-850. 2001
  • Guidelines of care for liposuction.  45:438-447. 2001
  • Ovarian hormones and adrenal androgens during a woman’s life span.  45:S105-S115. 2001
  • Surgical pearl: Hemostat-assisted nail avulsion revisited.  45:943-944. 2001
  • Tinea capitis of childhood: Incidence and pathogenetic role, of Trichophyton tonsurans in Central Europe [4] (multiple letters) [4].  45:320-321. 2001
  • A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.  43:641-648. 2000
  • Erratum: Tinea capitis: A current perspective (Journal of the American Academy of Dermatology (January 2000) 42 (1-20)).  42:704. 2000
  • Tinea capitis: A current perspective.  42:1-20. 2000
  • Tinea capitis: a current perspective..  42:1-20. 2000
  • Merkel cell carcinoma occurring in renal transplant patients..  41:289-291. 1999
  • Merkel cell carcinoma occurring in renal transplant patients.  41:289-291. 1999
  • Novel treatment strategies for superficial mycoses: Introduction.  40. 1999
  • Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method.  40:S9. 1999
  • Treatment of tinea capitis: Beyond griseofulvin.  40. 1999
  • Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail..  38:S87-S94. 1998
  • Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail..  38:S77-S86. 1998
  • Once-weekly fluconazole in the treatment of onychomycosis: introduction..  38:S73-S76. 1998
  • Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail..  38:S103-S109. 1998
  • Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail..  38:S110-S116. 1998
  • Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.  39:63-73. 1998
  • Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.  38. 1998
  • Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.  38. 1998
  • Once-weekly fluconazole in the treatment of onychomycosis: Introduction.  38. 1998
  • Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.  38. 1998
  • Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail.  38. 1998
  • Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial..  37:740-745. 1997
  • A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the tingemail.  36:231-235. 1997
  • Bacterial infection in a patient with onychomycosis.  37:493-494. 1997
  • One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: A multicenter, double-blind trial.  36. 1997
  • Onychomycosis in children: Prevalence and treatment strategies.  36:395-402. 1997
  • Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.  37:740-745. 1997
  • Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.  36. 1997
  • Diagnostic techniques for confirming onychomycosis..  35:S6-S9. 1996
  • Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study..  35:216-219. 1996
  • Reply.  35:135-135. 1996
  • Guidelines of care for superficial mycotic infections of the skin: Pityriasis (tinea) versicolor. Guidelines/Outcomes Committee. American Academy of Dermatology..  34:287-289. 1996
  • Guidelines of care for superficial mycotic infections of the skin: tinea capitis and tinea barbae. Guidelines/Outcomes Committee. American Academy of Dermatology..  34:290-294. 1996
  • Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology..  34:282-286. 1996
  • Surgical pearl: nail micronizer..  34:278. 1996
  • A U.S. epidemiologic survey of superficial fungal diseases.  35:539-542. 1996
  • Clinical pearl: Diagnostic procedures for tinea capitis.  34:498-499. 1996
  • Diagnostic techniques for confirming onychomycosis.  35. 1996
  • Guidelines of care for superficial mycotic infections of the skin: Mucocutaneous candidiasis.  34:110-115. 1996
  • Guidelines of care for superficial mycotic infections of the skin: Onychomycosis.  34:116-121. 1996
  • Guidelines of care for superficial mycotic infections of the skin: Piedra.  34:122-124. 1996
  • Intermittent fluconazole dosing in patients with onychomycosis: Results of a pilot study.  35:216-219. 1996
  • Onychomycosis caused by Scytalidium dimidiatum.  35:336-338. 1996
  • Surgical pearl: Nail micronizer.  34:278. 1996
  • Systemic antifungal drugs and drug interactions [2].  35:134-135. 1996
  • Thrombocytopenia caused by fluconazole [4].  35:284. 1996
  • Antifungal agents.  32:1060. 1995
  • Bonsai tree: Risk factor for disseminated sporotrichosis.  33:839-840. 1995
  • Clinical Pearl: Systemic antifungal drugs and drug interactions.  33:259-260. 1995
  • Clinical pearl: Diagnosis of onychomycosis.  32:500-501. 1995
  • Cost of therapy for dermatophyte infections.  32:1062. 1995
  • Cutaneous involvement with Cryptococcus neoformans in AIDS [4].  32:820-821. 1995
  • Cutaneous photosensitivity diseases induced by exogenous agents.  33:551-573. 1995
  • Failure of clotrimazole-betamethasone dipropionate cream in treatment of Microsporum canis infections.  32:1050-1051. 1995
  • Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole.  32:290-292. 1995
  • Reply.  32:821. 1995
  • Thrombocytopenia caused by fluconazole therapy.  32:525-526. 1995
  • Zosteriform zygomycosis.  32:357-361. 1995
  • Management of common superficial fungal infections in patients with AIDS..  31:S60-S63. 1994
  • Cutaneous involvement with Cryptococcus neoformans in AIDS.  30:844-848. 1994
  • Dermatophytes as opportunistic pathogens.  30:1021-1022. 1994
  • Introduction: International Summit on Cutaneous Antifungal Therapy.  31:S1. 1994
  • Management of common superficial fungal infections in patients with AIDS.  31:S60-S63. 1994
  • Tinea capitis: Itraconazole in Trichophyton tonsurans infection.  31:65-67. 1994
  • Malignant fibrous histiocytoma resembling mycetoma..  29:318-321. 1993
  • Mechanisms of action of systemic antifungal agents..  28:S28-S34. 1993
  • Clinical Pearl: Proximal white subungual onychomycosis in AIDS.  29:631-632. 1993
  • Malignant fibrous histiocytoma resembling mycetoma.  29:318-321. 1993
  • Mechanisms of action of systemic antifungal agents.  28:S28-S34. 1993
  • Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature..  24:706-714. 1991
  • Eosinophilic pustular folliculitis..  24:903-907. 1991
  • Childhood epidermolysis bullosa acquisita: Report of three cases and review of literature.  24:706-714. 1991
  • Eosinophilie pustular folliculitis.  24:903-907. 1991
  • Pigmented postacne osteoma cutis in a patient treated with minocycline: Report and review of the literature.  24:851-853. 1991
  • Leukocytoclastic vasculitis in a patient infected with human immunodeficiency virus..  21:1161-1164. 1989
  • The superficial mycoses and the dermatophytes..  21:655-673. 1989
  • Effects of occlusive and semiocclusive dressings on the return of barrier function to transepidermal water loss in standardized human wounds..  20:755-760. 1989
  • Effects of occlusive and semiocclusive dressings on the return of barrier function to transepidermal water loss in standardized human wounds.  20:755-760. 1989
  • Leukocytoclastic vasculitis in a patient infected with human immunodeficiency virus.  21:1161-1164. 1989
  • The superficial mycoses and the dermatophytes.  21:655-673. 1989
  • Antiviral treatment of a serious herpes simplex infection: Encephalitis.  18:209-211. 1988
  • Antiviral treatment of a serious herpes simplex infection: encephalitis..  18:209-211. 1988
  • Questions and answers.  18:207-208. 1988
  • Questions and answers.  18:222-223. 1988
  • Xanthogranulomatosis in an adult: Lipid analysis of xanthomas and plasma.  16:183-187. 1987
  • Xanthogranulomatosis in an adult: lipid analysis of xanthomas and plasma..  16:183-187. 1987
  • In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline.  8:807-812. 1983
  • International Standard Serial Number (issn)

  • 0190-9622
  • Electronic International Standard Serial Number (eissn)

  • 1097-6787